214 related articles for article (PubMed ID: 15795884)
1. Role of afterload reduction in the prevention of late anthracycline cardiomyopathy.
Silber JH
Pediatr Blood Cancer; 2005 Jun; 44(7):607-13. PubMed ID: 15795884
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic prevention of anthracycline-induced cardiomyopathy.
Maradia K; Guglin M
Cardiol Rev; 2009; 17(5):243-52. PubMed ID: 19690476
[TBL] [Abstract][Full Text] [Related]
3. Anthracycline-induced cardiomyopathy.
Simmons A; Vacek JL; Meyers D
Postgrad Med; 2008 Nov; 120(4):67-72. PubMed ID: 19020367
[TBL] [Abstract][Full Text] [Related]
4. Exposure to anthracyclines during childhood causes cardiac injury.
Lipshultz SE
Semin Oncol; 2006 Jun; 33(3 Suppl 8):S8-14. PubMed ID: 16781284
[TBL] [Abstract][Full Text] [Related]
5. Design and baseline characteristics for the ACE Inhibitor After Anthracycline (AAA) study of cardiac dysfunction in long-term pediatric cancer survivors.
Silber JH; Cnaan A; Clark BJ; Paridon SM; Chin AJ; Rychik J; Hogarty AN; Cohen MI; Barber G; Rutkowsky M; Kimball TR; Delaat C; Steinherz LJ; Zhao H; Tartaglione MR
Am Heart J; 2001 Oct; 142(4):577-85. PubMed ID: 11579345
[TBL] [Abstract][Full Text] [Related]
6. [Cardioprotection in women with neoplastic disease].
Cardinale D; Colombo A; Bacchiani G
G Ital Cardiol (Rome); 2012 Jun; 13(6):461-8. PubMed ID: 22622126
[TBL] [Abstract][Full Text] [Related]
7. [ACE inhibitors in the treatment of ventricular dysfunction caused by cardiotoxic cytostatics].
Mladosievicová B
Ceska Slov Farm; 2004 Mar; 53(2):55-60. PubMed ID: 15095572
[TBL] [Abstract][Full Text] [Related]
8. Anthracycline-induced cardiotoxicity in children with cancer: strategies for prevention and management.
Iarussi D; Indolfi P; Casale F; Martino V; Di Tullio MT; Calabrò R
Paediatr Drugs; 2005; 7(2):67-76. PubMed ID: 15871628
[TBL] [Abstract][Full Text] [Related]
9. [Anthracycline-induced cardiomyopathy].
Roul G; Cohen C; Lieber A
Presse Med; 2009 Jun; 38(6):987-94. PubMed ID: 19423276
[TBL] [Abstract][Full Text] [Related]
10. Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies.
Wouters KA; Kremer LC; Miller TL; Herman EH; Lipshultz SE
Br J Haematol; 2005 Dec; 131(5):561-78. PubMed ID: 16351632
[TBL] [Abstract][Full Text] [Related]
11. Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity.
Conklin KA
Integr Cancer Ther; 2005 Jun; 4(2):110-30. PubMed ID: 15911925
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology of anthracycline- and radiation-associated cardiomyopathies: implications for screening and prevention.
Adams MJ; Lipshultz SE
Pediatr Blood Cancer; 2005 Jun; 44(7):600-6. PubMed ID: 15856486
[TBL] [Abstract][Full Text] [Related]
13. Anthracycline-induced cardiotoxicity: clinical course, risk factors, pathogenesis, detection and prevention--review of the literature.
Wojtacki J; Lewicka-Nowak E; Leśniewski-Kmak K
Med Sci Monit; 2000; 6(2):411-20. PubMed ID: 11208348
[TBL] [Abstract][Full Text] [Related]
14. Strategies for reduction of anthracycline cardiac toxicity.
Speyer J; Wasserheit C
Semin Oncol; 1998 Oct; 25(5):525-37. PubMed ID: 9783592
[TBL] [Abstract][Full Text] [Related]
15. Cardiac Toxicity: Using Angiotensin-Converting Enzyme Inhibitors to Prevent Anthracycline-Induced Left Ventricular Dysfunction and Cardiomyopathy.
Kobza C
Clin J Oncol Nurs; 2021 Jun; 25(3):259-266. PubMed ID: 34019025
[TBL] [Abstract][Full Text] [Related]
16. [Chemotherapeutics-induced heart failure].
Paulides M; Wojnowski L
Med Klin (Munich); 2007 Jul; 102(7):574-8. PubMed ID: 17634876
[TBL] [Abstract][Full Text] [Related]
17. [Anthracyclines and the heart].
Mazzarello GP; Morra L
Recenti Prog Med; 1998 Sep; 89(9):459-64. PubMed ID: 9796378
[TBL] [Abstract][Full Text] [Related]
18. Dexrazoxane for the prevention of cardiomyopathy in anthracycline treated pediatric cancer patients.
Anderson B
Pediatr Blood Cancer; 2005 Jun; 44(7):584-8. PubMed ID: 15700251
[TBL] [Abstract][Full Text] [Related]
19. Pathology of late-onset anthracycline cardiomyopathy.
Bernaba BN; Chan JB; Lai CK; Fishbein MC
Cardiovasc Pathol; 2010; 19(5):308-11. PubMed ID: 19747852
[TBL] [Abstract][Full Text] [Related]
20. Prediction and prevention of chemotherapy-induced cardiomyopathy: can it be done?
Granger CB
Circulation; 2006 Dec; 114(23):2432-3. PubMed ID: 17146002
[No Abstract] [Full Text] [Related]
[Next] [New Search]
